CMC Development Strategies to Prevent Rework and Delays, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to reduce delays and improve efficiency in Chemistry, Manufacturing and Controls (CMC) development. The featured speaker will discuss and understand common obstacles, enabling teams to address them proactively and strengthen outcomes. Attendees will discover how leveraging digital platforms and structured processes can significantly reduce errors and enable more informed decision-making throughout the CMC lifecycle.

TORONTO, Oct. 21, 2025 /PRNewswire/ — Inefficiencies and errors in Chemistry, Manufacturing and Controls (CMC) development are a leading cause of regulatory delays, cost overruns and compromised product quality. As regulatory expectations evolve and product pipelines become more complex, life sciences organizations face growing pressure to modernize legacy CMC practices and mitigate risks early in development. This webinar will examine strategies and digital advancements that can minimize errors, streamline processes and ultimately optimize CMC development.

The featured speakers will start by outlining the fundamental ideas that underpin successful CMC procedures. From there, they will examine common challenges that often disrupt success, which may include inconsistent risk management activities, fragmented data sources, version control challenges and gaps in cross-functional collaboration. These pain points often lead to inefficiencies, increased costs and delayed regulatory submissions.

The webinar will also explore how risk-based decision-making, structured data management and enhanced knowledge exchange can help businesses better manage complexity and promote continuous improvement. By contrasting traditional techniques with more contemporary, integrated methods, the session will highlight ways to reduce variability and strengthen a culture of informed decision-making. Real-world case studies will demonstrate how various companies have transitioned from disconnected tools to fully integrated digital platforms.

Whether at the beginning of the CMC journey or seeking to refine existing practices, this session will provide practical guidance on how to proactively reduce errors, strengthen collaboration across teams and build a resilient foundation for long-term success in CMC development.

Register for this webinar to learn how to reduce delays and improve efficiency in CMC development.

Join Margarida Ventura, Senior Consultant, ValGenesis, for the live webinar on Wednesday, November 5, 2025, at 12pm EST (9am PST).

For more information, or to register for this event, visit CMC Development Strategies to Prevent Rework and Delays.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cmc-development-strategies-to-prevent-rework-and-delays-upcoming-webinar-hosted-by-xtalks-302589510.html

SOURCE Xtalks

Staff

Recent Posts

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

2 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

2 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

2 hours ago

A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…

5 hours ago

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

11 hours ago

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

17 hours ago